Wegovy (Semaglutide) vs Tirzepatide: What's the Difference
In contrast, treatment effects evaluated by the trial product estimand assumed that patients received the study drug for the duration of the trial and did not receive any additional blood glucose lowering medications (thereby aiming to reflect the effects of the study medications without the confounding effects of rescue medication or any other changes in glucose-lowering medication) [21]
These are known as drug-condition interactions
Flexible dosing options: Available in 0.25mg, 0.5mg, and 1.0mg, 1.7mg and 2,4mg doses, Wegovy allows for gradual adjustments based on individual needs, helping your healthcare provider determine the right dosage for you
GLP-1 Receptor Agonist Use Tied to Delayed Surgical Wound Healing THURSDAY, April 2, 2026 -- Glucagon-like peptide-1 (GLP-1) receptor agonist (RA) use is associated with delayed wound healing in patients undergoing abdominal panniculectomy, according to a study published in the April issue of Plastic and Reconstructive Surgery
So whats going on here